相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluating the Clinical Utility of a Biomarker A Review of Methods for Estimating Health Impact
Mark J. Pletcher et al.
CIRCULATION (2011)
Ascorbic acid for treatment in CMT1A: what's next?
Marianne de Visser et al.
LANCET NEUROLOGY (2011)
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial
Davide Pareyson et al.
LANCET NEUROLOGY (2011)
Morphometry of dermal nerve fibers in human skin
G. Lauria et al.
NEUROLOGY (2011)
Genetic and clinical aspects of Charcot-Marie-Tooth's disease
H. Skre
CLINICAL GENETICS (2010)
Foot Pad Skin Biopsy in Mouse Models of Hereditary Neuropathy
Patrizia Dacci et al.
GLIA (2010)
168th ENMC International Workshop: Outcome measures and clinical trials in Charcot–Marie–Tooth disease (CMT)
M.M. Reilly et al.
NEUROMUSCULAR DISORDERS (2010)
Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial
Camiel Verhamme et al.
BMC MEDICINE (2009)
PMP22 expression in dermal nerve myelin from patients with CMT1A
Istvan Katona et al.
BRAIN (2009)
Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A
Mario A. Saporta et al.
BRAIN (2009)
Hereditary predominantly motor neuropathies
Davide Pareyson et al.
CURRENT OPINION IN NEUROLOGY (2009)
Cholesterol Regulates the Endoplasmic Reticulum Exit of the Major Membrane Protein P0 Required for Peripheral Myelin Compaction
Gesine Saher et al.
JOURNAL OF NEUROSCIENCE (2009)
Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial
Joshua Burns et al.
LANCET NEUROLOGY (2009)
Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randornised, double-blind, placebo-control led trial
Joelle Micallef et al.
LANCET NEUROLOGY (2009)
Fat and beyond: The diverse biology of PPAR gamma
Peter Tontonoz et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Identifying modifier genes of monogenic disease: strategies and difficulties
Emmanuelle Genin et al.
HUMAN GENETICS (2008)
Increased severity over generations of Charcot-Marie-Tooth disease type 1A
Israel Steiner et al.
JOURNAL OF NEUROLOGY (2008)
Pioglitazone Attenuates Tactile Allodynia and Thermal Hyperalgesia in Mice Subjected to Peripheral Nerve Injury
Takehiko Maeda et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Neurophysiologic abnormalities in children with Charcot-Marie-Tooth disease type 1A
Eppie M. Yiu et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2008)
Neuropathy progression in Charcot-Marie-Tooth disease type 1A
M. E. Shy et al.
NEUROLOGY (2008)
The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints
Marissa N. Lassere
STATISTICAL METHODS IN MEDICAL RESEARCH (2008)
Thiazolidinedione class of peroxisome proliferator-activated receptor γ agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats
Seung-Won Park et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy
Gerd Meyer zu Horste et al.
ANNALS OF NEUROLOGY (2007)
Global transcriptome analysis of genetically identified neurons in the adult cortex
Moritz J. Rossner et al.
JOURNAL OF NEUROSCIENCE (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside
J Li et al.
BRAIN (2005)
Reliability and validity of the CMT neuropathy score as a measure of disability
ME Shy et al.
NEUROLOGY (2005)
Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis
T Vigo et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2005)
Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation
G Giambonini-Brugnoli et al.
NEUROBIOLOGY OF DISEASE (2005)
Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics
VK Mootha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A)
MW Sereda et al.
NATURE MEDICINE (2003)
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
Jo Vandesompele et al.
GENOME BIOLOGY (2002)
Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot-Marie-Tooth disease 1A duplication
J Berciano et al.
NEUROMUSCULAR DISORDERS (2000)
Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A
KM Krajewski et al.
BRAIN (2000)
Myelin synthesis in the peripheral nervous system
B Garbay et al.
PROGRESS IN NEUROBIOLOGY (2000)
分享论文
